More evidence needed on the benefits of CGM in children with type 1 and adults with type 2

SMBG

Previous systematic reviews and meta-analyses have failed to turn up clear evidence on the benefits and harms of continuous glucose monitoring (CGM) in children with type 1 diabetes and insulin-using patients with type 2 diabetes. This systematic review set out to update this state of affairs in the light of recent studies. In children with [read the full story…]

Continuous glucose monitoring may be effective and safe in type 1 diabetes compared with SMBG

CGM monitor

Clinical question In patients with type 1 diabetes, does Continuous glucose monitoring (CGM) compared with self-management of blood glucose (SMBG) lead to an improvement in glycaemic control or a reduction in hypoglycemia? Methods Systematic review of randomised trials.  14 trials were found, comprising 1,268 participants. Bottom line Real-time CGM was associated with a 0.26% (95% [read the full story…]

Share this post: Share on Facebook Tweet this on Twitter Share on LinkedIn Share on Google+ Share via email

Continuous glucose monitoring may improve glycaemic control

CGM monitor

This systematic review of randomised trials found nine studies that investigated whether continuous glucose monitoring (CGM) compared with self-monitoring of blood glucose (SMBG) led to improved glycaemic control or a reduction in hypoglycaemic episodes. The reviewers combined the results of the study in a meta-analysis to measure the benefit of CGM compared with conventional treatment [read the full story…]

Share this post: Share on Facebook Tweet this on Twitter Share on LinkedIn Share on Google+ Share via email